Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Polymorphisms of adrenergic cardiovascular control genes are associated with adolescent chronic fatigue syndrome.
Sommerfeldt L, Portilla H, Jacobsen L, Gjerstad J, Wyller VB.
Acta Paediatr. 2011 Feb;100(2):293-8. doi: 10.1111/j.1651-2227.2010.02072.x. Epub 2010 Nov 18.
Related citations
Moderate exercise increases expression for sensory, adrenergic, and immune genes in chronic fatigue syndrome patients but not in normal subjects.
Light AR, White AT, Hughen RW, Light KC.
J Pain. 2009 Oct;10(10):1099-112. doi: 10.1016/j.jpain.2009.06.003. Epub 2009 Jul 31.
Combinations of single nucleotide polymorphisms in neuroendocrine effector and receptor genes predict chronic fatigue syndrome.
Goertzel BN, Pennachin C, de Souza Coelho L, Gurbaxani B, Maloney EM, Jones JF.
Pharmacogenomics. 2006 Apr;7(3):475-83.
Autoantibodies, polymorphisms in the serotonin pathway, and human leukocyte antigen class II alleles in chronic fatigue syndrome: are they associated with age at onset and specific symptoms?
Ortega-Hernandez OD, Cuccia M, Bozzini S, Bassi N, Moscavitch S, Diaz-Gallo LM, Blank M, Agmon-Levin N, Shoenfeld Y.
Ann N Y Acad Sci. 2009 Sep;1173:589-99. doi: 10.1111/j.1749-6632.2009.04802.x.
Genetic polymorphisms of adrenergic receptors.
Garland EM, Biaggioni I.
Clin Auton Res. 2001 Apr;11(2):67-78. Review.
Glucocorticoid receptor polymorphisms and haplotypes associated with chronic fatigue syndrome.
Rajeevan MS, Smith AK, Dimulescu I, Unger ER, Vernon SD, Heim C, Reeves WC.
Genes Brain Behav. 2007 Mar;6(2):167-76.
Adrenergic gene polymorphisms and cardiovascular risk in the NHLBI-sponsored Women's Ischemia Syndrome Evaluation.
Pacanowski MA, Zineh I, Li H, Johnson BD, Cooper-DeHoff RM, Bittner V, McNamara DM, Sharaf BL, Merz CN, Pepine CJ, Johnson JA.
J Transl Med. 2008 Mar 10;6:11. doi: 10.1186/1479-5876-6-11.
An integrated approach to infer causal associations among gene expression, genotype variation, and disease.
Lee E, Cho S, Kim K, Park T.
Genomics. 2009 Oct;94(4):269-77. doi: 10.1016/j.ygeno.2009.06.002. Epub 2009 Jun 18.
Association between chronic fatigue syndrome and the corticosteroid-binding globulin gene ALA SER224 polymorphism.
Torpy DJ, Bachmann AW, Gartside M, Grice JE, Harris JM, Clifton P, Easteal S, Jackson RV, Whitworth JA.
Endocr Res. 2004 Aug;30(3):417-29.
A first study of cytokine genomic polymorphisms in CFS: Positive association of TNF-857 and IFNgamma 874 rare alleles.
Carlo-Stella N, Badulli C, De Silvestri A, Bazzichi L, Martinetti M, Lorusso L, Bombardieri S, Salvaneschi L, Cuccia M.
Clin Exp Rheumatol. 2006 Mar-Apr;24(2):179-82.
Genetic evaluation of the serotonergic system in chronic fatigue syndrome.
Smith AK, Dimulescu I, Falkenberg VR, Narasimhan S, Heim C, Vernon SD, Rajeevan MS.
Psychoneuroendocrinology. 2008 Feb;33(2):188-97.
[Catechol-O-methyltransferase gene rs6267 polymorphism in children with attention deficit hyperactivity disorder].
Zhang YB, Luo XR, Liu X, Zhong Y, Zhu F, Chen LY.
Zhongguo Dang Dai Er Ke Za Zhi. 2011 Feb;13(2):127-30. Chinese.
Molecular study of receptor for advanced glycation endproduct gene promoter and identification of specific HLA haplotypes possibly involved in chronic fatigue syndrome.
Carlo-Stella N, Bozzini S, De Silvestri A, Sbarsi I, Pizzochero C, Lorusso L, Martinetti M, Cuccia M.
Int J Immunopathol Pharmacol. 2009 Jul-Sep;22(3):745-54.
Identification of marker genes for differential diagnosis of chronic fatigue syndrome.
Saiki T, Kawai T, Morita K, Ohta M, Saito T, Rokutan K, Ban N.
Mol Med. 2008 Sep-Oct;14(9-10):599-607. doi: 10.2119/2007-00059.Saiki.
Adrenergic signaling polymorphisms and their impact on cardiovascular disease.
Dorn GW 2nd.
Physiol Rev. 2010 Jul;90(3):1013-62. doi: 10.1152/physrev.00001.2010.
An angiotensin-1 converting enzyme polymorphism is associated with allostatic load mediated by C-reactive protein, interleukin-6 and cortisol.
Smith AK, Maloney EM, Falkenberg VR, Dimulescu I, Rajeevan MS.
Psychoneuroendocrinology. 2009 May;34(4):597-606. doi: 10.1016/j.psyneuen.2008.10.022. Epub 2008 Dec 10.
Human liver catechol-O-methyltransferase pharmacogenetics.
Boudíková B, Szumlanski C, Maidak B, Weinshilboum R.
Clin Pharmacol Ther. 1990 Oct;48(4):381-9.
Dopaminergic candidate genes in Tourette syndrome: association between tic severity and 3' UTR polymorphism of the dopamine transporter gene.
Tarnok Z, Ronai Z, Gervai J, Kereszturi E, Gadoros J, Sasvari-Szekely M, Nemoda Z.
Am J Med Genet B Neuropsychiatr Genet. 2007 Oct 5;144B(7):900-5.
Significance of catechol-O-methyltransferase gene polymorphism in fibromyalgia syndrome.
Gürsoy S, Erdal E, Herken H, Madenci E, Alaşehirli B, Erdal N.
Rheumatol Int. 2003 May;23(3):104-7. Epub 2002 Oct 22.
Genetic polymorphisms of estrogen receptor alpha, CYP19, catechol-O-methyltransferase are associated with familial prostate carcinoma risk in a Japanese population.
Suzuki K, Nakazato H, Matsui H, Koike H, Okugi H, Kashiwagi B, Nishii M, Ohtake N, Nakata S, Ito K, Yamanaka H.
Cancer. 2003 Oct 1;98(7):1411-6.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on